Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 1
2016 pubmed 26 citations

Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity.

Uthaisar. Kwuntida K; Vaeteewoottacharn. Kulthida K; Seubwai. Wunchana W; Talabnin. Chutima C; Sawanyawisuth. Kanlayanee K; Obchoei. Sumalee S; Kraiklang. Ratthaphol R; Okada. Seiji S; Wongkham. Sopit S

Key Findings

  • A highly metastatic cholangiocarcinoma cell line (KKU-213L5) was established and shows stronger growth and invasion than its parent line.
  • KKU-213L5 cells have much higher AGR2 expression and markedly lower KiSS-1 (kisspeptin) expression.
  • Low KiSS-1/kisspeptin levels were also observed in higher‑stage cholangiocarcinoma patient samples, linking it to metastasis.

Practical Outcomes

  • The work suggests kisspeptin may act as a natural brake on cancer spread, but it provides no concrete advice or dosage for people. For now, it’s mainly a research finding that could inspire future anti‑cancer strategies, not a usable protocol for longevity or performance.

Summary

Scientists created a new liver cancer cell line that spreads to the lungs a lot. This aggressive line grows faster, invades more, and shows higher levels of a protein called AGR2 and lower levels of the KiSS-1 gene, which makes the peptide kisspeptin. In real patient tumors, low kisspeptin also showed up in more advanced cancers, hinting it might help stop cancer spread, but the study doesn’t give any direct health tips for everyday use.

Abstract

Cholangiocarcinoma (CCA) is a highly metastatic tumor, and the lung is a common site of metastasis. A greater understanding of the biology of metastases is needed to improve treatment outcomes. Herein, a highly metastatic human CCA subline, KKU-213L5 from an original cell line, KKU-213 that has marginally metastatic ability, was established and characterized. KKU-213L5 was selected in vivo through the fifth serial passage of pulmonary metastasized tissues via tail-vein injection in NOD/scid/Jak3 mice. The metastatic abilities of the KKU-213L5 cells were compared with the parental line in vitro and in vivo. The expression profile of this metastatic cell line was determined using real-time PCR. KKU-213L5 cells were found to possess higher metastatic phenotypes, i.e., growth rates, stem cell surface markers (CD133), migration and invasion characteristics when compared with the parental cells. Compared to the KKU-213 cells, KKU-213L5 cells formed larger tumors in subcutaneous xenografted mice and had a >10-fold increase in lung metastases in the tail-vein injected metastatic mouse model. Mice injected intravenously with KKU-213L5 cells had a significantly shorter survival. Analysis of the expressed genes related to progression of cancer revealed significant upregulation of anterior gradient protein-2 (AGR2) and suppression of KiSS-1 in the KKU-213L5 cells. The association of these two genes with metastasis was affirmed in CCA patient tissues since increased AGR2 expression and decreased KiSS-1 expression were found in higher stage patient tumors. In conclusion, a highly metastatic human CCA cell line was established and characterized. It is plausible that the differential expression between the parental KKU-213 and highly metastatic KKU-213L5 cells may be beneficial to classify novel genes associated with metastasis. The KKU-213L5 cell line should serve as a valued device for discovering the molecular mechanisms of CCA metastasis and enabling the search for an effective therapy for the unmet clinical need in CCA.

Study Information

Provider

pubmed

Year

2016

Date

2016-07-25T00:00:00.000Z

DOI

10.3892/or.2016.4974

Citations

26

References

46